{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T03:48:38Z","timestamp":1794282518294,"version":"4.9.0"},"reference-count":135,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T00:00:00Z","timestamp":1767571200000},"content-version":"vor","delay-in-days":35,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-29721-9","type":"journal-article","created":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T06:04:50Z","timestamp":1764569090000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Formulation, development and characterization of fosfomycin tromethamine pessaries for the treatment of vaginal infections"],"prefix":"10.1038","volume":"16","author":[{"given":"Mahboob Ul","family":"Haq","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Attiqa","family":"Naz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdul","family":"Baseer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sajjad","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Basmah F.","family":"Alharbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Khurram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,1]]},"reference":[{"key":"29721_CR1","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1128\/CMR.00068-15","volume":"29","author":"ME Falagas","year":"2016","unstructured":"Falagas, M. E., Vouloumanou, E. K., Samonis, G. & Vardakas, K. Z. Fosfomycin. Clin. Microbiol. Rev. 29, 321\u2013347 (2016).","journal-title":"Clin. Microbiol. Rev."},{"key":"29721_CR2","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0167-7306(08)60406-8","volume":"27","author":"J Van Heijenoort","year":"1994","unstructured":"Van Heijenoort, J. Biosynthesis of the bacterial peptidoglycan unit.. New Comprehensive Biochemistry 27, 39\u201354 (1994).","journal-title":"New Comprehensive Biochemistry"},{"key":"29721_CR3","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1002\/phar.2780","volume":"43","author":"MT Tran","year":"2023","unstructured":"Tran, M. T. New ways of using old antibiotics in pediatrics: focus on fosfomycin. Pharmacother J. Hum. Pharmacol. Drug Ther. 43, 705\u2013712 (2023).","journal-title":"Pharmacother J. Hum. Pharmacol. Drug Ther."},{"key":"29721_CR4","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1080\/14787210.2019.1573669","volume":"17","author":"G Dimopoulos","year":"2019","unstructured":"Dimopoulos, G. et al. Intravenous fosfomycin for the treatment of multidrug-resistant pathogens: what is the evidence on dosing regimens? Expert Rev. Anti Infect. Ther. 17, 201\u2013210 (2019).","journal-title":"Expert Rev. Anti Infect. Ther."},{"key":"29721_CR5","doi-asserted-by":"crossref","first-page":"637","DOI":"10.2165\/00003495-199753040-00007","volume":"53","author":"SS Patel","year":"1997","unstructured":"Patel, S. S., Balfour, J. A. & Bryson, H. M. Fosfomycin tromethamine: a review of its antibacterial activity, Pharmacokinetic properties and therapeutic efficacy as a single-dose oral treatment for acute uncomplicated lower urinary tract infections. Drugs 53, 637\u2013656 (1997).","journal-title":"Drugs"},{"key":"29721_CR6","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0022-3565(25)28008-9","volume":"162","author":"GR Wilkinson","year":"1968","unstructured":"Wilkinson, G. R. & Beckett, A. H. Absorption, metabolism and excretion of the ephedrines in man. I. The influence of urinary pH and urine volume output. J. Pharmacol. Exp. Ther. 162, 139\u2013147 (1968).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"29721_CR7","doi-asserted-by":"crossref","first-page":"S65","DOI":"10.1007\/BF01643430","volume":"18","author":"T Bergan","year":"1990","unstructured":"Bergan, T. Degree of absorption, pharmacokinetics of fosfomycin Trometamol and duration of urinary antibacterial activity. Infection 18, S65\u2013S69 (1990).","journal-title":"Infection"},{"key":"29721_CR8","doi-asserted-by":"crossref","unstructured":"P\u00e9rez, D. S., Soraci, A. L. & Tapia, M. O. Pharmacokinetics and bioavailability of calcium fosfomycin in post weaning piglets after oral administration. (2012).","DOI":"10.5455\/ijavms.20130111041914"},{"key":"29721_CR9","first-page":"1","volume":"32","author":"FJ Candel","year":"2019","unstructured":"Candel, F. J., David, M. M. & L\u00f3pez, J. B. New perspectives for reassessing fosfomycin: applicability in current clinical practice. Rev. Esp. Quimioter. 32, 1 (2019).","journal-title":"Rev. Esp. Quimioter"},{"key":"29721_CR10","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/j.vaccine.2015.01.040","volume":"33","author":"P Oyarzun","year":"2015","unstructured":"Oyarzun, P. et al. A bioinformatics tool for epitope-based vaccine design that accounts for human ethnic diversity: application to emerging infectious diseases. Vaccine 33, 1267\u20131273 (2015).","journal-title":"Vaccine"},{"key":"29721_CR11","first-page":"10","volume":"61","author":"E Wenzler","year":"2017","unstructured":"Wenzler, E., Ellis-Grosse, E. J. & Rodvold, K. A. Pharmacokinetics, safety, and tolerability of single-dose intravenous (ZTI-01) and oral fosfomycin in healthy volunteers. Antimicrob. Agents Chemother. 61, 10\u20131128 (2017).","journal-title":"Antimicrob. Agents Chemother."},{"key":"29721_CR12","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s10096-009-0833-2","volume":"29","author":"M Popovic","year":"2010","unstructured":"Popovic, M., Steinort, D., Pillai, S. & Joukhadar, C. Fosfomycin: an old, new friend? Eur. J. Clin. Microbiol. Infect. Dis. 29, 127\u2013142 (2010).","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"29721_CR13","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1016\/j.clinthera.2008.11.015","volume":"30","author":"LV Allen Jr","year":"2008","unstructured":"Allen, L. V. Jr Dosage form design and development. Clin. Ther. 30, 2102\u20132111 (2008).","journal-title":"Clin. Ther."},{"key":"29721_CR14","unstructured":"Candel, F. J., David, M. M., L\u00f3pez, J. B., David, F. J. & L\u00f3pez, J. B. New perspectives for reassessing fosfomycin: applicability in current clinical practiceCandel,M. M., New perspectives for reassessing fosfomycin: applicability in current clinical practice. Revista Espanola de Quimiot. Rev. Esp. Quimioter. 32, 1 (2019). (2019)."},{"key":"29721_CR15","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/s41392-019-0068-3","volume":"4","author":"AP Singh","year":"2019","unstructured":"Singh, A. P., Biswas, A., Shukla, A. & Maiti, P. Targeted therapy in chronic diseases using nanomaterial-based drug delivery vehicles. Signal. Transduct. Target. Ther. 4, 33 (2019).","journal-title":"Signal. Transduct. Target. Ther."},{"key":"29721_CR16","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1089\/jwh.2014.5140","volume":"24","author":"F Fabbian","year":"2015","unstructured":"Fabbian, F. et al. Is female gender as harmful as bacteria? Analysis of hospital admissions for urinary tract infections in elderly patients. J. Women\u2019s Heal. 24, 587\u2013592 (2015).","journal-title":"J. Women\u2019s Heal"},{"key":"29721_CR17","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1080\/1040841X.2017.1306688","volume":"44","author":"S Kovachev","year":"2018","unstructured":"Kovachev, S. Defence factors of vaginal lactobacilli. Crit. Rev. Microbiol. 44, 31\u201339 (2018).","journal-title":"Crit. Rev. Microbiol."},{"key":"29721_CR18","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1186\/s12879-016-1888-1","volume":"16","author":"PC Matthews","year":"2016","unstructured":"Matthews, P. C. et al. Oral fosfomycin for treatment of urinary tract infection: a retrospective cohort study. BMC Infect. Dis. 16, 556 (2016).","journal-title":"BMC Infect. Dis."},{"key":"29721_CR19","doi-asserted-by":"crossref","first-page":"5602","DOI":"10.1128\/AAC.00752-15","volume":"59","author":"F Docobo-P\u00e9rez","year":"2015","unstructured":"Docobo-P\u00e9rez, F. et al. Pharmacodynamics of fosfomycin: insights into clinical use for antimicrobial resistance. Antimicrob. Agents Chemother. 59, 5602\u20135610 (2015).","journal-title":"Antimicrob. Agents Chemother."},{"key":"29721_CR20","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1515\/cipms-2015-0039","volume":"28","author":"B Chudzik-Rzad","year":"2015","unstructured":"Chudzik-Rzad, B., Andrzejczuk, S., Rzad, M., Tomasiewicz, K. & Malm, A. Overview on fosfomycin and its current and future clinical significance. Curr. Issues Pharm. Med. Sci. 28, 33\u201336 (2015).","journal-title":"Curr. Issues Pharm. Med. Sci."},{"key":"29721_CR21","doi-asserted-by":"crossref","first-page":"672429","DOI":"10.3389\/fcimb.2021.672429","volume":"11","author":"L Abou Chacra","year":"2022","unstructured":"Abou Chacra, L., Fenollar, F. & Diop, K. Bacterial vaginosis: what do we currently know? Front. Cell. Infect. Microbiol. 11, 672429 (2022).","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"29721_CR22","doi-asserted-by":"crossref","first-page":"e34540","DOI":"10.1371\/journal.pone.0034540","volume":"7","author":"CS Bradshaw","year":"2012","unstructured":"Bradshaw, C. S. et al. Efficacy of oral metronidazole with vaginal clindamycin or vaginal probiotic for bacterial vaginosis: randomised placebo-controlled double-blind trial. PLoS One. 7, e34540 (2012).","journal-title":"PLoS One"},{"key":"29721_CR23","doi-asserted-by":"crossref","first-page":"108","DOI":"10.3390\/microorganisms12010108","volume":"12","author":"JD Sobel","year":"2024","unstructured":"Sobel, J. D. & Vempati, Y. S. Bacterial vaginosis and vulvovaginal candidiasis pathophysiologic interrelationship. Microorganisms 12, 108 (2024).","journal-title":"Microorganisms"},{"key":"29721_CR24","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/s41429-021-00444-z","volume":"74","author":"C Dos Santos","year":"2021","unstructured":"Dos Santos, C., Santos, D., Franco, O. L. & L. S. & Fosfomycin and nitrofurantoin: classic antibiotics and perspectives. J. Antibiot. (Tokyo). 74, 547\u2013558 (2021).","journal-title":"J. Antibiot. (Tokyo)"},{"key":"29721_CR25","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1093\/jac\/dkr466","volume":"67","author":"DE Karageorgopoulos","year":"2012","unstructured":"Karageorgopoulos, D. E., Wang, R., Yu, X. & Falagas, M. E. Fosfomycin: evaluation of the published evidence on the emergence of antimicrobial resistance in Gram-negative pathogens. J. Antimicrob. Chemother. 67, 255\u2013268 (2012).","journal-title":"J. Antimicrob. Chemother."},{"key":"29721_CR26","doi-asserted-by":"crossref","unstructured":"da Silva, L. E., Confortin, C. & Swamy, M. K. Antibacterial and antifungal plant metabolites from the tropical medicinal plants. in Bioactive Natural Products for Pharmaceutical Applications 263\u2013285Springer, (2020).","DOI":"10.1007\/978-3-030-54027-2_7"},{"key":"29721_CR27","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s13595-024-01241-y","volume":"81","author":"Y Brodrechtova","year":"2024","unstructured":"Brodrechtova, Y., Majlingov\u00e1, A. & Sedm\u00e1k, R. Stakeholders\u2019 participation in decreasing wildfire risk in the context of natural resource management in the Podpo\u013eanie region of Slovakia. Ann. Sci. 81, 25 (2024).","journal-title":"Ann. Sci."},{"key":"29721_CR28","doi-asserted-by":"crossref","first-page":"121112","DOI":"10.1016\/j.ijpharm.2021.121112","volume":"608","author":"M Spoerk","year":"2021","unstructured":"Spoerk, M. et al. Personalised urethra pessaries prepared by material extrusion-based additive manufacturing. Int. J. Pharm. 608, 121112 (2021).","journal-title":"Int. J. Pharm."},{"key":"29721_CR29","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1186\/s12905-025-03923-9","volume":"25","author":"O Ol\u00e1h","year":"2025","unstructured":"Ol\u00e1h, O. et al. Demographic, socioeconomic and functional health-related factors in the selection of vaginal pessaries used for the Conservative treatment of pelvic organ prolapse: a retrospective study. BMC Womens Health. 25, 390 (2025).","journal-title":"BMC Womens Health"},{"key":"29721_CR30","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/s41573-023-00670-0","volume":"22","author":"TH Baryakova","year":"2023","unstructured":"Baryakova, T. H., Pogostin, B. H., Langer, R. & McHugh, K. J. Overcoming barriers to patient adherence: the case for developing innovative drug delivery systems. Nat. Rev. Drug Discov. 22, 387\u2013409 (2023).","journal-title":"Nat. Rev. Drug Discov"},{"key":"29721_CR31","doi-asserted-by":"crossref","first-page":"e75068","DOI":"10.1371\/journal.pone.0075068","volume":"8","author":"G Mart\u00ednez","year":"2013","unstructured":"Mart\u00ednez, G., Perez, D. S., Soraci, A. L. & Tapia, M. O. Penetration of fosfomycin into IPEC-J2 cells in the presence or absence of Deoxynivalenol. PLoS One. 8, e75068 (2013).","journal-title":"PLoS One"},{"key":"29721_CR32","unstructured":"Roonasi, P. & Holmgren, A. A study on the mechanism of magnetite formation based on iron isotope fractionation. in TMS 2009 Annual Meeting and Exhibition: 15\/02\/2009-19\/02\/2009 829\u2013836 (Minerals, Metals & Materials Society, (2009)."},{"key":"29721_CR33","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1080\/19440049.2019.1675909","volume":"37","author":"R Valand","year":"2020","unstructured":"Valand, R., Tanna, S., Lawson, G. & Bengtstr\u00f6m, L. A review of fourier transform infrared (FTIR) spectroscopy used in food adulteration and authenticity investigations. Food Addit. Contam. Part. A. 37, 19\u201338 (2020).","journal-title":"Food Addit. Contam. Part. A"},{"key":"29721_CR34","doi-asserted-by":"crossref","first-page":"109511","DOI":"10.1016\/j.porgcoat.2025.109511","volume":"208","author":"A Malik","year":"2025","unstructured":"Malik, A., Barnab\u00e9, S. & Loranger, \u00c9. Synthesis, formulation, and characterization of a bio-based paint derived from TOCN and polypyrrole. Prog Org. Coat. 208, 109511 (2025).","journal-title":"Prog Org. Coat."},{"issue":"35","key":"29721_CR35","doi-asserted-by":"crossref","first-page":"6963","DOI":"10.1039\/D5SM00420A","volume":"21","author":"J Pajoubpong","year":"2025","unstructured":"Pajoubpong, J. et al. Deciphering supramolecular and polymer-like behavior in metallogels: real-time insights into temperature-modulated gelation and rapid self-assembly dynamics. Soft Matter. 21(35), 6963\u20136975 (2025).","journal-title":"Soft Matter."},{"key":"29721_CR36","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1099\/jmm.0.002046","volume":"74","author":"M Obermeier","year":"2025","unstructured":"Obermeier, M. et al. Non-antifungal medications administered during fungal infections drive drug tolerance and resistance in Candida albicans. J. Med. Microbiol. 74, 2046 (2025).","journal-title":"J. Med. Microbiol."},{"key":"29721_CR37","doi-asserted-by":"crossref","unstructured":"Akash, M. S. H. & Rehman, K. Comprehensive Insights into Thermo Gravimetric Analysis. in Essentials of Pharmaceutical Analysis 899\u2013929Springer, (2025).","DOI":"10.1007\/978-981-96-5996-8_19"},{"key":"29721_CR38","doi-asserted-by":"publisher","DOI":"10.5114\/wo.2014.47136","author":"K Tomczak","year":"2015","unstructured":"Tomczak, K., Czerwi\u0144ska, P. & Wiznerowicz, M. The cancer genome atlas (TCGA): an immeasurable source of knowledge. Contemp. Oncol. Onkol. https:\/\/doi.org\/10.5114\/wo.2014.47136 (2015).","journal-title":"Contemp. Oncol. Onkol."},{"key":"29721_CR39","first-page":"100538","volume":"22","author":"R Aniza","year":"2024","unstructured":"Aniza, R., Chen, W. H., Kwon, E. E., Bach, Q. V. & Hoang, A. T. Lignocellulosic biofuel properties and reactivity analyzed by thermogravimetric analysis (TGA) toward zero carbon scheme: A critical review. Energy Convers. Manag X. 22, 100538 (2024).","journal-title":"Energy Convers. Manag X"},{"key":"29721_CR40","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1002\/cjce.23673","volume":"98","author":"N Saadatkhah","year":"2020","unstructured":"Saadatkhah, N. et al. Experimental methods in chemical engineering: thermogravimetric analysis\u2014TGA. Can. J. Chem. Eng. 98, 34\u201343 (2020).","journal-title":"Can. J. Chem. Eng."},{"key":"29721_CR41","doi-asserted-by":"crossref","first-page":"179680","DOI":"10.1016\/j.tca.2024.179680","volume":"733","author":"C Wang","year":"2024","unstructured":"Wang, C., Chazallon, C., Braymand, S. & Hornych, P. Thermogravimetric analysis (TGA) for characterization of self-cementation of recycled concrete aggregates in pavement. Thermochim Acta. 733, 179680 (2024).","journal-title":"Thermochim Acta"},{"key":"29721_CR42","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1002\/ese3.1627","volume":"12","author":"Y Li","year":"2024","unstructured":"Li, Y., Li, J., Zhou, S., Meng, B. & Wu, T. A review on thermogravimetric analysis-based analyses of the pyrolysis kinetics of oil shale and coal. Energy Sci. Eng. 12, 329\u2013355 (2024).","journal-title":"Energy Sci. Eng."},{"key":"29721_CR43","doi-asserted-by":"crossref","first-page":"161","DOI":"10.2174\/0115734129300562240408042614","volume":"20","author":"A Singhal","year":"2024","unstructured":"Singhal, A. et al. Uv-visible spectroscopy: a review on its pharmaceutical and bio-allied sciences applications. Curr. Pharm. Anal. 20, 161\u2013177 (2024).","journal-title":"Curr. Pharm. Anal."},{"key":"29721_CR44","first-page":"261","volume":"15","author":"AR Ghuge","year":"2025","unstructured":"Ghuge, A. R., Dhole, S. N., Kulkarni, N. S. & Medankar, T. B. Rectal suppositories for treatment of inflammatory bowel disease: A review. Asian J. Pharm. Technol. 15, 261\u2013270 (2025).","journal-title":"Asian J. Pharm. Technol."},{"key":"29721_CR45","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/B978-0-323-91150-4.00021-5","volume-title":"Non-destructive material characterization methods","author":"K Khalid","year":"2024","unstructured":"Khalid, K., Ishak, R. & Chowdhury, Z. Z. UV\u2013Vis spectroscopy in non-destructive testing. In Non-destructive material characterization methods 391\u2013416 (Elsevier, 2024)."},{"key":"29721_CR46","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1002\/9783527848133.ch20","volume":"1","author":"PS Kanojiya","year":"2024","unstructured":"Kanojiya, P. S., Karemore, M. N. & Wadetwar, R. N. Biopolymers for vaginal delivery. Biopolym Pharm. Food Appl. 1, 417\u2013449 (2024).","journal-title":"Biopolym Pharm. Food Appl."},{"key":"29721_CR47","doi-asserted-by":"crossref","unstructured":"Yessa, E. Y., Wientarsih, I., Ulum, M. F., Purwantara, B. & Amrozi, A. The potential of biodegradable polymers: Chitosan, polyethylene glycol, and Polycaprolactone as materials for progesterone intravaginal devices. Livest Anim. Res 22, 11\u201324 .","DOI":"10.20961\/lar.v22i1.72985"},{"key":"29721_CR48","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.reactfunctpolym.2016.01.011","volume":"100","author":"S Mansuri","year":"2016","unstructured":"Mansuri, S. et al. A promising approach in drug delivery system. React. Funct. Polym. 100, 151\u2013172 (2016).","journal-title":"React. Funct. Polym."},{"key":"29721_CR49","doi-asserted-by":"crossref","first-page":"129578","DOI":"10.1016\/j.seppur.2024.129578","volume":"355","author":"C Zhang","year":"2025","unstructured":"Zhang, C. et al. Detection methodologies and mechanisms of reactive oxygen species generated in Fenton\/Fenton-like processes. Sep. Purif. Technol. 355, 129578 (2025).","journal-title":"Sep. Purif. Technol."},{"key":"29721_CR50","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s12911-024-02485-4","volume":"24","author":"M Momeni","year":"2024","unstructured":"Momeni, M., Afkanpour, M., Rakhshani, S., Mehrabian, A. & Tabesh, H. A prediction model based on artificial intelligence techniques for disintegration time and hardness of fast disintegrating tablets in pre-formulation tests. BMC Med. Inf. Decis. Mak. 24, 88 (2024).","journal-title":"BMC Med. Inf. Decis. Mak."},{"key":"29721_CR51","first-page":"16","volume":"6","author":"C Sahoo","year":"2017","unstructured":"Sahoo, C., Sudhakar, K., Ramana, M., V, D. & Satyanarayana, K. A discussion on quality control of suppositories. MJPMS 6, 16\u201318 (2017).","journal-title":"MJPMS"},{"key":"29721_CR52","doi-asserted-by":"crossref","unstructured":"Yao, C., Zhong, H. & Zhu, Z. Development of a large shaking table test for sand liquefaction analysis. Lithosphere lithosphere_2024_137 (2024). (2024).","DOI":"10.2113\/2024\/lithosphere_2024_137"},{"key":"29721_CR53","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3390\/scipharm92010010","volume":"92","author":"K Barton\u00edkov\u00e1","year":"2024","unstructured":"Barton\u00edkov\u00e1, K., \u0160paglov\u00e1, M., Papadakos, M., Hanko, M. & Macho, O. Mucoadhesive vaginal tablets containing metronidazole: screening of optimal natural polymer in the composition. Sci. Pharm. 92, 10 (2024).","journal-title":"Sci. Pharm."},{"key":"29721_CR54","unstructured":"Bchkol, D. H. K., Abdulkareem, A. H. & Habib, F. A. A Study on Quality Control Tests for Dosage Forms and their Effect on Physical (A Review, )."},{"issue":"2","key":"29721_CR55","first-page":"668","volume":"2","author":"KM Lakshmi","year":"2024","unstructured":"Lakshmi, K. M. & Reddy, N. D. A review on suppositories. Int J. Pharm. 2(2), 668\u2013675 (2024).","journal-title":"Int J. Pharm."},{"issue":"8","key":"29721_CR56","doi-asserted-by":"crossref","first-page":"100110","DOI":"10.1016\/j.lddd.2025.100110","volume":"22","author":"S Mirza","year":"2025","unstructured":"Mirza, S. et al. Development and characterization of suppository formulation for rectal delivery of clarithromycin. Lett Drug Des. Discov. 22(8), 100110 (2025).","journal-title":"Lett Drug Des. Discov."},{"key":"29721_CR57","first-page":"3","volume":"3","author":"KA Jones","year":"2010","unstructured":"Jones, K. A. & Harmanli, O. Z. Pessary use in pelvic organ prolapse and urinary incontinence. Rev. Obstet. Gynecol. 3, 3 (2010).","journal-title":"Rev. Obstet. Gynecol."},{"key":"29721_CR58","doi-asserted-by":"crossref","first-page":"30951","DOI":"10.1038\/s41598-024-81985-9","volume":"14","author":"F van den Noort","year":"2024","unstructured":"van den Noort, F. et al. Analysing the support mechanisms of the vaginal ring Pessary on supine and upright MRI. Sci. Rep. 14, 30951 (2024).","journal-title":"Sci. Rep."},{"key":"29721_CR59","doi-asserted-by":"crossref","unstructured":"Golembiovska, O., Dmytrenko, O. & Galkin, A. Design and development of novel herbal suppository formulation for prostatitis treatment. (2024).","DOI":"10.20535\/ibb.2024.8.4.317124"},{"key":"29721_CR60","doi-asserted-by":"crossref","unstructured":"Khalid, N., Darmon, M. & Chaix, J. F. Advanced Homogenization Model for Ultrasonic Non-Destructive Testing of Concrete and its Validation. in 51st Annual Review of Progress in Quantitative Nondestructive Evaluation vol. 88162 V001T01A003American Society of Mechanical Engineers, (2024).","DOI":"10.1115\/QNDE2024-134694"},{"key":"29721_CR61","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1208\/s12248-025-01107-9","volume":"27","author":"Z Gao","year":"2025","unstructured":"Gao, Z. & Smith, A. Response to the commentary from A dissolution working group on the effect of sampling cannula on in vitro dissolution testing with USP paddle method: clarifications and opportunities for engagement. AAPS J. 27, 120 (2025).","journal-title":"AAPS J."},{"key":"29721_CR62","doi-asserted-by":"crossref","first-page":"119164","DOI":"10.1016\/j.powtec.2023.119164","volume":"432","author":"I Bashir","year":"2024","unstructured":"Bashir, I. et al. Effect of freeze drying and spray drying on physical properties, morphology and in vitro release kinetics of vitamin D3 nanoparticles. Powder Technol. 432, 119164 (2024).","journal-title":"Powder Technol."},{"key":"29721_CR63","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1080\/10837450.2024.2341243","volume":"29","author":"FN Abdelrazek","year":"2024","unstructured":"Abdelrazek, F. N. et al. Novel fast dissolving freeze dried Sublingual Baicalin tablets for enhanced hepatoprotective effect: in-vitro characterization, cell viability, and in-vivo evaluation. Pharm. Dev. Technol. 29, 371\u2013382 (2024).","journal-title":"Pharm. Dev. Technol."},{"key":"29721_CR64","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1002\/bmc.3183","volume":"28","author":"M Gumustas","year":"2014","unstructured":"Gumustas, M., Sengel-Turk, C. T., Hascicek, C. & Ozkan, S. A. Optimization of a validated stability\u2010indicating RP\u2010LC method for the determination of fulvestrant from polymeric based nanoparticle systems, drugs and biological samples. Biomed. Chromatogr. 28, 1409\u20131417 (2014).","journal-title":"Biomed. Chromatogr."},{"key":"29721_CR65","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1007\/s10337-013-2477-8","volume":"76","author":"M Gumustas","year":"2013","unstructured":"Gumustas, M., Kurbanoglu, S., Uslu, B. & Ozkan, S. A. UPLC versus HPLC on drug analysis: advantageous, applications and their validation parameters. Chromatographia 76, 1365\u20131427 (2013).","journal-title":"Chromatographia"},{"key":"29721_CR66","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.contraception.2015.11.008","volume":"93","author":"R Rastogi","year":"2016","unstructured":"Rastogi, R. et al. Engineering and characterization of simplified vaginal and seminal fluid simulants. Contraception 93, 337\u2013346 (2016).","journal-title":"Contraception"},{"key":"29721_CR67","unstructured":"Laferriere, C. Euthanasia in laboratory rodents: alternatives to intraperitoneal injection of sodium pentobarbital. (2020)."},{"key":"29721_CR68","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1128\/CVI.00411-10","volume":"18","author":"MS Patgaonkar","year":"2011","unstructured":"Patgaonkar, M. S., Sathe, A., Selvaakumar, C. & Reddy, K. V. R. A rabbit vaginal cell-derived antimicrobial peptide, RVFHb\u03b1P, blocks lipopolysaccharide-mediated inflammation in human vaginal cells in vitro. Clin. Vaccine Immunol. 18, 1632\u20131643 (2011).","journal-title":"Clin. Vaccine Immunol."},{"key":"29721_CR69","doi-asserted-by":"crossref","first-page":"651426","DOI":"10.3389\/fmicb.2021.651426","volume":"12","author":"C Fan","year":"2021","unstructured":"Fan, C. et al. Aerobic vaginitis induced by Escherichia coli infection during pregnancy can result in adverse pregnancy outcomes through the IL-4\/JAK-1\/STAT-6 pathway. Front. Microbiol. 12, 651426 (2021).","journal-title":"Front. Microbiol."},{"key":"29721_CR70","doi-asserted-by":"crossref","first-page":"12729","DOI":"10.3390\/ijms241612729","volume":"24","author":"W Lee","year":"2023","unstructured":"Lee, W. et al. Molecular and genomic analysis of the virulence factors and potential transmission of hybrid enteropathogenic and enterotoxigenic Escherichia coli (EPEC\/ETEC) strains isolated in South Korea. Int. J. Mol. Sci. 24, 12729 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"29721_CR71","unstructured":"Pathak, M. Controlled delivery of antibacterials using Polycaprolactone matrices for the intravaginal treatment of sexually transmitted infections. (2016)."},{"key":"29721_CR72","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1177\/0885328214528256","volume":"29","author":"M Pathak","year":"2014","unstructured":"Pathak, M., Turner, M., Palmer, C. & Coombes, A. G. A. Evaluation of Polycaprolactone matrices for the intravaginal delivery of metronidazole in the treatment of bacterial vaginosis. J. Biomater. Appl. 29, 354\u2013363 (2014).","journal-title":"J. Biomater. Appl."},{"key":"29721_CR73","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1093\/humrep\/dey288","volume":"33","author":"IJM Duijkers","year":"2018","unstructured":"Duijkers, I. J. M. et al. Effect on endometrial histology and pharmacokinetics of different dose regimens of progesterone vaginal pessaries, in comparison with progesterone vaginal gel and placebo. Hum. Reprod. 33, 2131\u20132140 (2018).","journal-title":"Hum. Reprod."},{"key":"29721_CR74","unstructured":"Kipo, S. L. et al. Development and In Vitro Evaluation of Oral Gels and Vaginal Pessaries from Crude Extracts of Four Ghanaian Medicinal Plants Intended for the Treatment Of Candidiasis. (2015)."},{"key":"29721_CR75","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1111\/bcp.16029","volume":"90","author":"K Thakur","year":"2024","unstructured":"Thakur, K. et al. Development and verification of mechanistic vaginal absorption and metabolism model to predict systemic exposure after vaginal ring and gel application. Br. J. Clin. Pharmacol. 90, 1428\u20131449 (2024).","journal-title":"Br. J. Clin. Pharmacol."},{"key":"29721_CR76","doi-asserted-by":"crossref","first-page":"667","DOI":"10.5732\/cjc.012.10271","volume":"32","author":"XH Zheng","year":"2013","unstructured":"Zheng, X. H., Cui, C., Zhou, X. X., Zeng, Y. X. & Jia, W. H. Centrifugation: an important pre-analytic procedure that influences plasma MicroRNA quantification during blood processing. Chin. J. Cancer. 32, 667 (2013).","journal-title":"Chin. J. Cancer"},{"key":"29721_CR77","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1097\/OLQ.0b013e31816766af","volume":"35","author":"N Khanna","year":"2008","unstructured":"Khanna, N. et al. Phase I clinical trial of repeat dose terameprocol vaginal ointment in healthy female volunteers. Sex. Transm Dis. 35, 577\u2013582 (2008).","journal-title":"Sex. Transm Dis."},{"key":"29721_CR78","doi-asserted-by":"crossref","first-page":"101955","DOI":"10.1016\/j.jddst.2020.101955","volume":"60","author":"A Pandit","year":"2020","unstructured":"Pandit, A., Kedar, A. & Koyate, K. Hollow Pessary loaded with Lawsone via self-microemulsifying drug delivery system for vaginal candidiasis. J. Drug Deliv Sci. Technol. 60, 101955 (2020).","journal-title":"J. Drug Deliv Sci. Technol."},{"key":"29721_CR79","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1007\/s11095-022-03230-0","volume":"39","author":"P Chryssafidis","year":"2022","unstructured":"Chryssafidis, P., Tsekouras, A. A. & Macheras, P. Re-writing oral Pharmacokinetics using physiologically based finite time Pharmacokinetic (PBFTPK) models. Pharm. Res. 39, 691\u2013701 (2022).","journal-title":"Pharm. Res."},{"key":"29721_CR80","doi-asserted-by":"crossref","first-page":"3103","DOI":"10.1007\/s00210-024-03468-y","volume":"398","author":"M Gaikwad","year":"2025","unstructured":"Gaikwad, M. et al. Development and characterization of formulations based on combinatorial potential of antivirals against genital herpes. Naunyn Schmiedebergs Arch. Pharmacol. 398, 3103\u20133117 (2025).","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"29721_CR81","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1111\/bcp.13822","volume":"85","author":"O de Filho","year":"2018","unstructured":"de Filho, O. Pharmacokinetics and pharmacodynamics of three dosages of oestriol after continuous vaginal ring administration for 21 days in healthy, postmenopausal women. Br. J. Clin. Pharmacol. 85, 551 (2018).","journal-title":"Br. J. Clin. Pharmacol."},{"key":"29721_CR82","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/pro.4213","volume":"31","author":"SK Burley","year":"2022","unstructured":"Burley, S. K. et al. RCSB protein data bank: celebrating 50 years of the PDB with new tools for Understanding and visualizing biological macromolecules in 3D. Protein Sci. 31, 187\u2013208 (2022).","journal-title":"Protein Sci."},{"key":"29721_CR83","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.1017\/S0033583525000034","volume":"58","author":"HM Berman","year":"2025","unstructured":"Berman, H. M. & Burley, S. K. Protein data bank (PDB): Fifty-three years young and having a transformative impact on science and society. Q. Rev. Biophys. 58, e9 (2025).","journal-title":"Q. Rev. Biophys."},{"key":"29721_CR84","doi-asserted-by":"crossref","first-page":"15225","DOI":"10.1038\/s41598-024-78411-5","volume":"15","author":"A Kumar","year":"2025","unstructured":"Kumar, A. et al. Molecular dynamics simulation and Docking studies reveals Inhibition of NF-kB signaling as a promising therapeutic drug target for reduction in cytokines storms. Sci. Rep. 15, 15225 (2025).","journal-title":"Sci. Rep."},{"key":"29721_CR85","doi-asserted-by":"crossref","first-page":"W363","DOI":"10.1093\/nar\/gky473","volume":"46","author":"W Tian","year":"2018","unstructured":"Tian, W., Chen, C., Lei, X., Zhao, J. & Liang, J. CASTp 3.0: computed atlas of surface topography of proteins. Nucleic Acids Res. 46, W363\u2013W367 (2018).","journal-title":"Nucleic Acids Res."},{"key":"29721_CR86","doi-asserted-by":"crossref","unstructured":"Kondapuram, S. K., Sarvagalla, S. & Coumar, M. S. Docking-based virtual screening using PyRx Tool: autophagy target Vps34 as a case study. in Molecular Docking for Computer-Aided Drug Design 463\u2013477Elsevier, (2021).","DOI":"10.1016\/B978-0-12-822312-3.00019-9"},{"key":"29721_CR87","doi-asserted-by":"crossref","first-page":"132","DOI":"10.5958\/0974-4150.2021.00014.6","volume":"14","author":"RP Pawar","year":"2021","unstructured":"Pawar, R. P. & Rohane, S. H. Role of Autodock Vina in pyrx molecular Docking. Asian J. Res. Chem. 14, 132\u2013134 (2021).","journal-title":"Asian J. Res. Chem."},{"key":"29721_CR88","doi-asserted-by":"crossref","first-page":"10742","DOI":"10.3390\/ijerph191710742","volume":"19","author":"A Alshammari","year":"2022","unstructured":"Alshammari, A. et al. Novel chimeric vaccine candidate development against leptotrichia buccalis. Int. J. Environ. Res. Public. Health. 19, 10742 (2022).","journal-title":"Int. J. Environ. Res. Public. Health"},{"key":"29721_CR89","doi-asserted-by":"crossref","first-page":"168","DOI":"10.56782\/pps.261","volume":"22","author":"F \u0130slamo\u011flu","year":"2024","unstructured":"\u0130slamo\u011flu, F. Molecular docking, bioactivity, ADME, toxicity risks, and quantum mechanical parameters of some 1, 2-dihydroquinoline derivatives were calculated theoretically for investigation of its use as a pharmaceutical active ingredient in the treatment of multiple. Prospect. Pharm. Sci. 22, 168\u2013187 (2024).","journal-title":"Prospect. Pharm. Sci."},{"key":"29721_CR90","doi-asserted-by":"crossref","first-page":"134242","DOI":"10.1016\/j.molstruc.2022.134242","volume":"1273","author":"A Fatima","year":"2023","unstructured":"Fatima, A. et al. DFT, molecular docking, molecular dynamics simulation, MMGBSA calculation and Hirshfeld surface analysis of 5-sulfosalicylic acid. J. Mol. Struct. 1273, 134242 (2023).","journal-title":"J. Mol. Struct."},{"key":"29721_CR91","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1021\/acs.jctc.1c01217","volume":"18","author":"CJ Dickson","year":"2022","unstructured":"Dickson, C. J., Walker, R. C. & Gould, I. R. Lipid21: complex lipid membrane simulations with AMBER. J. Chem. Theory Comput. 18, 1726\u20131736 (2022).","journal-title":"J. Chem. Theory Comput."},{"key":"29721_CR92","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0010-4655(95)00041-D","volume":"91","author":"DA Pearlman","year":"1995","unstructured":"Pearlman, D. A. et al. AMBER, a package of computer programs for applying molecular mechanics, normal mode analysis, molecular dynamics and free energy calculations to simulate the structural and energetic properties of molecules. Comput. Phys. Commun. 91, 1\u201341 (1995).","journal-title":"Comput. Phys. Commun."},{"key":"29721_CR93","doi-asserted-by":"crossref","first-page":"9954","DOI":"10.1021\/jp003020w","volume":"105","author":"P Mark","year":"2001","unstructured":"Mark, P. & Nilsson, L. Structure and dynamics of the TIP3P, SPC, and SPC\/E water models at 298 K. J. Phys. Chem. A. 105, 9954\u20139960 (2001).","journal-title":"J. Phys. Chem. A"},{"key":"29721_CR94","doi-asserted-by":"crossref","first-page":"257","DOI":"10.5114\/bta.2021.108722","volume":"102","author":"S Ghosh","year":"2021","unstructured":"Ghosh, S., Chetia, D., Gogoi, N. & Rudrapal, M. Design, molecular docking, drug-likeness, and molecular dynamics studies of 1,2,4-trioxane derivatives as novel plasmodium falciparum falcipain-2 (Fp-2) inhibitors. Biotechnologia 102, 257\u2013275 (2021).","journal-title":"Biotechnologia"},{"key":"29721_CR95","doi-asserted-by":"publisher","DOI":"10.2174\/0113862073334062241015043343","author":"B Siddiqui","year":"2025","unstructured":"Siddiqui, B. et al. Artificial intelligence in computer-aided drug design (cadd) tools for the finding of potent biologically active small molecules: Traditional to modern approach. Comb Chem. High. Throughput Screen https:\/\/doi.org\/10.2174\/0113862073334062241015043343 (2025).","journal-title":"Comb Chem. High. Throughput Screen"},{"key":"29721_CR96","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1002\/1096-987X(20010415)22:5<501::AID-JCC1021>3.0.CO;2-V","volume":"22","author":"V Kr\u00e4utler","year":"2001","unstructured":"Kr\u00e4utler, V., Van Gunsteren, W. F. & H\u00fcnenberger, P. H. A fast SHAKE algorithm to solve distance constraint equations for small molecules in molecular dynamics simulations. J. Comput. Chem. 22, 501\u2013508 (2001).","journal-title":"J. Comput. Chem."},{"key":"29721_CR97","doi-asserted-by":"crossref","first-page":"4262","DOI":"10.1039\/D4RA07951E","volume":"15","author":"B Chafer-Dolz","year":"2025","unstructured":"Chafer-Dolz, B. et al. Discovery of novel acetylcholinesterase inhibitors through AI-powered structure prediction and high-performance computing-enhanced virtual screening. RSC Adv. 15, 4262\u20134273 (2025).","journal-title":"RSC Adv."},{"key":"29721_CR98","doi-asserted-by":"crossref","first-page":"3084","DOI":"10.1021\/ct400341p","volume":"9","author":"DR Roe","year":"2013","unstructured":"Roe, D. R. & Cheatham, T. E. III PTRAJ and CPPTRAJ: software for processing and analysis of molecular dynamics trajectory data. J. Chem. Theory Comput. 9, 3084\u20133095 (2013).","journal-title":"J. Chem. Theory Comput."},{"key":"29721_CR99","unstructured":"Turner, P. J. & XMGRACE Version 5.1. 19. Cent coast land-margin Res. Or. Grad Inst. Sci. Technol. Beaverton, OR (2005)."},{"key":"29721_CR100","doi-asserted-by":"crossref","first-page":"8103","DOI":"10.3390\/molecules27228103","volume":"27","author":"K Miandad","year":"2022","unstructured":"Miandad, K. et al. Virtual screening of Artemisia annua phytochemicals as potential inhibitors of SARS-CoV-2 main protease enzyme. Molecules 27, 8103 (2022).","journal-title":"Molecules"},{"key":"29721_CR101","doi-asserted-by":"crossref","first-page":"9478","DOI":"10.1021\/acs.chemrev.9b00055","volume":"119","author":"E Wang","year":"2019","unstructured":"Wang, E. et al. End-point binding free energy calculation with MM\/PBSA and MM\/GBSA: strategies and applications in drug design. Chem. Rev. 119, 9478\u20139508 (2019).","journal-title":"Chem. Rev."},{"key":"29721_CR102","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1517\/17460441.2015.1032936","volume":"10","author":"S Genheden","year":"2015","unstructured":"Genheden, S. & Ryde, U. The MM\/PBSA and MM\/GBSA methods to estimate ligand-binding affinities. Expert Opin. Drug Discov. 10, 449\u2013461 (2015).","journal-title":"Expert Opin. Drug Discov"},{"key":"29721_CR103","doi-asserted-by":"crossref","unstructured":"Okoye, K. & Hosseini, S. Analysis of variance (ANOVA) in R: one-way and two-way ANOVA. in R programming: statistical data analysis in research 187\u2013209Springer, (2024).","DOI":"10.1007\/978-981-97-3385-9_9"},{"key":"29721_CR104","first-page":"e939065","volume":"29","author":"A Gunay","year":"2023","unstructured":"Gunay, A. et al. Comparison of antibacterial activity, cytotoxicity, and fluoride release of glass ionomer restorative dental cements in dentistry. Med. Sci. Monit. Int. Med. J. Exp. Clin. Res. 29, e939065\u2013e939061 (2023).","journal-title":"Med. Sci. Monit. Int. Med. J. Exp. Clin. Res."},{"key":"29721_CR105","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1007\/s11095-021-03065-1","volume":"38","author":"COS Sorzano","year":"2021","unstructured":"Sorzano, C. O. S., Fonseca-Reyna, Y. & de la Cruz-Moreno, M. A. P. Scipion PKPD: an Open-Source platform for Biopharmaceutics, pharmacokinetics and pharmacodynamics data analysis. Pharm. Res. 38, 1169\u20131178 (2021).","journal-title":"Pharm. Res."},{"key":"29721_CR106","doi-asserted-by":"crossref","first-page":"361","DOI":"10.4314\/bcse.v32i2.14","volume":"32","author":"H Saedi","year":"2018","unstructured":"Saedi, H. Preparation and assessment of prostaglandin E2 formulated with hydroxypropyl Methyl cellulose and span 60 sustained release pessaries (vaginal suppositories). Bull. Chem. Soc. Ethiop. 32, 361\u2013370 (2018).","journal-title":"Bull. Chem. Soc. Ethiop."},{"key":"29721_CR107","unstructured":"LING, L. Evaluation and characterisation of bioadhesive suppositories formulated using commercial hydrogenated palm kernel stearin. (2015)."},{"key":"29721_CR108","doi-asserted-by":"crossref","first-page":"589","DOI":"10.2174\/1871520619666191211110640","volume":"20","author":"D Negi","year":"2020","unstructured":"Negi, D., Singh, A., Joshi, N. & Mishra, N. Cisplatin and probiotic biomass loaded pessaries for the management of cervical cancer. Anti-Cancer Agents Med. Chem. (Formerly Curr. Med. Chem. Agents). 20, 589\u2013598 (2020).","journal-title":"Anti-Cancer Agents Med. Chem. (Formerly Curr. Med. Chem. Agents)"},{"key":"29721_CR109","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1038\/nsb0902-646","volume":"9","author":"M Karplus","year":"2002","unstructured":"Karplus, M. & McCammon, J. A. Molecular dynamics simulations of biomolecules. Nat. Struct. Biol. 9, 646\u2013652 (2002).","journal-title":"Nat. Struct. Biol."},{"key":"29721_CR110","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/s41572-025-00626-1","volume":"11","author":"CS Bradshaw","year":"2025","unstructured":"Bradshaw, C. S. et al. Bacterial vaginosis. Nat. Rev. Dis. Prim. 11, 43 (2025).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"29721_CR111","doi-asserted-by":"crossref","first-page":"100163","DOI":"10.1016\/j.bea.2025.100163","volume":"9","author":"B Fotouh","year":"2025","unstructured":"Fotouh, B., Kyser, A. J., Mahmoud, M. Y. & Frieboes, H. B. Dual probiotic and antibiotic therapy targeting bacterial vaginosis: an integrated experimental\/computational modeling perspective. Biomed. Eng. Adv. 9, 100163 (2025).","journal-title":"Biomed. Eng. Adv."},{"key":"29721_CR112","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/EBP.0000000000002284","volume":"28","author":"MP Bagingito","year":"2025","unstructured":"Bagingito, M. P. & Trang, D. T. Is one dose of fosfomycin as effective as a five-day course of Nitrofurantoin at achieving clinical cure of uncomplicated cystitis in pregnant women? Evidence-Based Pract. 28, 14\u201315 (2025).","journal-title":"Evidence-Based Pract."},{"key":"29721_CR113","doi-asserted-by":"publisher","DOI":"10.1093\/jpp\/rgaf045","author":"E Sanchez Armengol","year":"2025","unstructured":"Sanchez Armengol, E. et al. Exploring the potential of vaginal drug delivery: innovations, efficacy, and therapeutic prospects. J Pharm. Pharmacol. https:\/\/doi.org\/10.1093\/jpp\/rgaf045 (2025).","journal-title":"J Pharm. Pharmacol."},{"key":"29721_CR114","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1007\/s40265-013-0143-y","volume":"73","author":"GM Keating","year":"2013","unstructured":"Keating, G. M. Fosfomycin trometamol: a review of its use as a single-dose oral treatment for patients with acute lower urinary tract infections and pregnant women with asymptomatic bacteriuria. Drugs 73, 1951\u20131966 (2013).","journal-title":"Drugs"},{"key":"29721_CR115","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.anaerobe.2017.05.005","volume":"47","author":"MAB Petrina","year":"2017","unstructured":"Petrina, M. A. B., Cosentino, L. A., Rabe, L. K. & Hillier, S. L. Susceptibility of bacterial vaginosis (BV)-associated bacteria to secnidazole compared to metronidazole, Tinidazole and clindamycin. Anaerobe 47, 115\u2013119 (2017).","journal-title":"Anaerobe"},{"key":"29721_CR116","doi-asserted-by":"crossref","unstructured":"Li, T. et al. Treatment of bacterial vaginosis: a comparison of metronidazole and clindamycin on human anaerobic bacteria and lactobacilli. (2020).","DOI":"10.21203\/rs.3.rs-107727\/v1"},{"key":"29721_CR117","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/2082693","author":"GG Zhanel","year":"2016","unstructured":"Zhanel, G. G., Walkty, A. J. & Karlowsky, J. A. Fosfomycin: a first-line oral therapy for acute uncomplicated cystitis.. Can. J. Infect. Dis. Med. Microbiol. https:\/\/doi.org\/10.1155\/2016\/2082693 (2016).","journal-title":"Can. J. Infect. Dis. Med. Microbiol."},{"key":"29721_CR118","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1002\/phar.1434","volume":"34","author":"JL Reffert","year":"2014","unstructured":"Reffert, J. L. & Smith, W. J. Fosfomycin for the treatment of resistant gram-negative bacterial infections: insights from the society of infectious diseases pharmacists. Pharmacother J. Hum. Pharmacol. Drug Ther. 34, 845\u2013857 (2014).","journal-title":"Pharmacother J. Hum. Pharmacol. Drug Ther."},{"key":"29721_CR119","doi-asserted-by":"crossref","first-page":"621","DOI":"10.3390\/idr14040067","volume":"14","author":"A Marino","year":"2022","unstructured":"Marino, A. et al. Oral fosfomycin formulation in bacterial prostatitis: new role for an old molecule-brief literature review and clinical considerations. Infect. Dis. Rep. 14, 621\u2013634 (2022).","journal-title":"Infect. Dis. Rep."},{"key":"29721_CR120","doi-asserted-by":"crossref","first-page":"e732","DOI":"10.1016\/j.ijid.2011.07.007","volume":"15","author":"AS Michalopoulos","year":"2011","unstructured":"Michalopoulos, A. S., Livaditis, I. G. & Gougoutas, V. The revival of fosfomycin. Int. J. Infect. Dis. 15, e732\u2013e739 (2011).","journal-title":"Int. J. Infect. Dis."},{"key":"29721_CR121","first-page":"164","volume":"47","author":"F Foglia","year":"2024","unstructured":"Foglia, F. et al. Aerobic vaginitis: antibiotic resistance trend and future actions of antimicrobial diagnostic stewardship. New. Microbiol. 47, 164\u2013171 (2024).","journal-title":"New. Microbiol."},{"key":"29721_CR122","first-page":"1173","volume":"25","author":"E Costantini","year":"2014","unstructured":"Costantini, E. et al. Prulifloxacin vs fosfomycin for prophylaxis in female patients with recurrent utis: a non-inferiority trial. Int. Urogynecol. J. 25, 1173\u20131178 (2014).","journal-title":"Int. Urogynecol. J."},{"key":"29721_CR123","doi-asserted-by":"crossref","first-page":"26","DOI":"10.4103\/0974-7796.148585","volume":"7","author":"A Sultan","year":"2015","unstructured":"Sultan, A. et al. Increasing antimicrobial resistance among uropathogens: is fosfomycin the answer? Urol. Ann. 7, 26\u201330 (2015).","journal-title":"Urol. Ann."},{"key":"29721_CR124","unstructured":"Arora, D. & Fosfomycin antimicrobial and clinical efficacy review. (2024)."},{"key":"29721_CR125","first-page":"2889","volume":"33","author":"A Darabniya","year":"2025","unstructured":"Darabniya, A. Anti-inflammatory and immunomodulatory properties of fosfomycin: an overlooked potential in a well-known antibiotic. Inflammopharmacology 33, 2889\u20132894 (2025).","journal-title":"Inflammopharmacology"},{"key":"29721_CR126","first-page":"256","volume":"96","author":"J Paavonen","year":"2000","unstructured":"Paavonen, J., Mangioni, C., Martin, M. A. & Wajszczuk, C. P. Vaginal clindamycin and oral metronidazole for bacterial vaginosis: a randomized trial. Obstet. Gynecol. 96, 256\u2013260 (2000).","journal-title":"Obstet. Gynecol."},{"key":"29721_CR127","first-page":"2","volume":"2","author":"S Borges","year":"2016","unstructured":"Borges, S., Barbosa, J. & Teixeira, P. Drug delivery systems for vaginal Infections. Frontiers in clinical drug research: anti-infectives. Bentham Sci. Publ. 2, 2\u201328 (2016).","journal-title":"Bentham Sci. Publ"},{"key":"29721_CR128","doi-asserted-by":"crossref","first-page":"77","DOI":"10.17350\/HJSE19030000334","volume":"11","author":"G Baysal","year":"2024","unstructured":"Baysal, G. Investigation of barrier effectiveness and comfort properties of biodegradable PLA nonwoven fabrics coated with unmodified lignin\/water-borne polyurethane composite coatings. Hittite J. Sci. Eng. 11, 77\u201388 (2024).","journal-title":"Hittite J. Sci. Eng."},{"key":"29721_CR129","doi-asserted-by":"crossref","first-page":"305","DOI":"10.3390\/antibiotics13040305","volume":"13","author":"A B\u0101rzdi\u0146a","year":"2024","unstructured":"B\u0101rzdi\u0146a, A. et al. From polymeric nanoformulations to polyphenols\u2014strategies for enhancing the efficacy and drug delivery of gentamicin. Antibiotics 13, 305 (2024).","journal-title":"Antibiotics"},{"key":"29721_CR130","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1007\/s10118-014-1515-9","volume":"32","author":"S Venkatesan","year":"2014","unstructured":"Venkatesan, S., Ranjithkumar, B., Rajeshkumar, S. & Anver Basha, K. Synthesis, characterization, thermal stability and antibacterial activity of coumarin based methacrylate copolymers. Chin. J. Polym. Sci. 32, 1373\u20131380 (2014).","journal-title":"Chin. J. Polym. Sci."},{"key":"29721_CR131","doi-asserted-by":"publisher","DOI":"10.4137\/CMWH.S32156","author":"M Khrouf","year":"2016","unstructured":"Khrouf, M. et al. Progesterone for luteal phase support in in vitro fertilization: comparison of vaginal and rectal pessaries to vaginal capsules: a randomized controlled study.. \u00a0Clin. Med.\u00a0 https:\/\/doi.org\/10.4137\/CMWH.S32156 (2016).","journal-title":"Clin. Med."},{"key":"29721_CR132","doi-asserted-by":"crossref","first-page":"4492","DOI":"10.1128\/JCM.43.9.4492-4497.2005","volume":"43","author":"MN Austin","year":"2005","unstructured":"Austin, M. N., Beigi, R. H., Meyn, L. A. & Hillier, S. L. Microbiologic response to treatment of bacterial vaginosis with topical clindamycin or metronidazole. J. Clin. Microbiol. 43, 4492\u20134497 (2005).","journal-title":"J. Clin. Microbiol."},{"key":"29721_CR133","unstructured":"Nagarjuna, J. Formulation and Evaluation of Chloroquine Phosphate Suppositories. at (2012)."},{"key":"29721_CR134","unstructured":"Gwimo, W. A. Development and characterisation of miconazole nitrate loaded solid lipid nanoparticles for incorporation into a vaginal mucoadhesive system. Signature 12, (2019)."},{"key":"29721_CR135","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s40121-015-0092-8","volume":"4","author":"D Iarikov","year":"2015","unstructured":"Iarikov, D., Wassel, R., Farley, J. & Nambiar, S. Adverse events associated with fosfomycin use: review of the literature and analyses of the FDA adverse event reporting system database. Infect. Dis. Ther. 4, 433\u2013458 (2015).","journal-title":"Infect. Dis. Ther."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-29721-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-29721-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-29721-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T14:41:56Z","timestamp":1767624116000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-29721-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,1]]},"references-count":135,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["29721"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-29721-9","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,1]]},"assertion":[{"value":"1 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study is reported according to ARRIVE guidelines.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"ARRIVE guidelines"}}],"article-number":"381"}}